Informes de Expertos’ Post

According to The Semaglutide Revolution Market Study, published by Medical Insight, found that 72% of aesthetic clinics currently offer GLP-1 medications for weight loss. The Semaglutide Revolution Market Study includes the latest market data on Impact on Aesthetic Industry, Patient Volume, Online Rx, Medspa Revenues, Five-Year Forecast and Survey Results. Obtain the most comprehensive market data with a copy of The Semaglutide Revolution Market Study: https://lnkd.in/gvD4Kmv Email questions to Leah Morvant: lmorvant@miinews.com #marketstudies #marketresearch #marketresearchreports #medicalinsight #marketdata #marketintelligence #aestheticindustry

According to The Semaglutide Revolution Market Study, published by Medical Insight, found that 72% of aesthetic clinics currently offer GLP-1 medications for weight loss. The Semaglutide Revolution Market Study includes the latest market data on Impact on Aesthetic Industry, Patient Volume, Online Rx, Medspa Revenues, Five-Year Forecast and Survey Results. Obtain the most comprehensive market data with a copy of The Semaglutide Revolution Market Study: https://lnkd.in/gvD4Kmv Email questions to Leah Morvant: lmorvant@miinews.com #marketstudies #marketresearch #marketresearchreports #medicalinsight #marketdata #marketintelligence #aestheticindustry

Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses GENEVA--(BUSINESS WIRE)--Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses via Business Wire Health: Medical Devices News

𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 Prophecy Market Insights 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐬𝐮𝐜𝐭𝐢𝐨𝐧 𝐢𝐧𝐬𝐭𝐫𝐮𝐦𝐞𝐧𝐭𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟔𝟎𝟒.𝟓𝟖 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟏𝟎𝟒𝟔.𝟏𝟑 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟒, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟔.𝟐%. The Surgical Suction Instruments Market is undergoing remarkable growth, driven by advancements in precision and patient care. These instruments are vital for maintaining clear surgical fields, minimizing risks, and ensuring optimal outcomes. Curious about the latest trends, market dynamics, and key players shaping the future of this market? Discover insights on: ✅ Market size and forecast ✅ Technological innovations ✅ Regional growth trends 📄 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐡𝐞𝐫𝐞: https://lnkd.in/gA8NPMR2 Key Players Includes: Medtronic | Olympus Corporation | Stryker | Johnson & Johnson | CONMED Corporation | PENTAX Medical | Hollister Incorporated | Smith+Nephew | KARL STORZ | Boston Scientific | Richard Wolf GmbH

On the week of #WorldCreativityandInnovationDay, I'd like to emphasize the importance of discovering moments of creativity amidst the fast-paced routine of leadership. Here are three creativity tips for busy executives. - Embrace the Power of Small Ideas: Creativity isn't always about groundbreaking solutions. Daily, small ideas hold intrinsic value and can serve as the spark that ignites something extraordinary. - Seek Inspiration: Creativity can also be rearranging old ideas in fresh and innovative ways. Therefore, don't hesitate to tap into various sources for inspiration, whether it be conversation with a colleague or a stranger, a book, or an inspiring movie. You never know what might trigger your next significant breakthrough. - Slow Down: Quality ideas thrive in a tranquil environment. In our hyperconnected world, we tend to fill every moment with stimulation. However, allowing ourselves a few minutes of boredom—such as during a coffee break or while waiting for the elevator—can enable our brains to generate novel insights. Creativity is an ongoing exercise, and by giving ourselves moments to slow down, we’ll find ourselves better equipped to tackle challenges head-on. Last but not least, I'll recall Friedrich Merz's motto, "Do it differently than others, and do it better," which embodies embracing creativity to solve problems. Marcela Bhering A. and I discuss the innovative mindset of Merz Aesthetics aesth in the post below. Check it out! #MerzAesthetics #WorldCreativityDay #BusyLeaders #Creativity #Leadership #Innovation 

Confidence is the key focus of Merz Aesthetics. It's what drives us every day – not just to fuel confidence in our customers and patients, but also in our team members. I got the chance to share a few insights about how confidence shapes our business. Check out the video in the link below! #MerzAesthetics #ConfidenceToBe #Confidence #MedicalAesthetics 

Outstanding comfort and precise vision even at 16 hours of wear!(1) I'm proud to be a part of the PRECISION7® launch today in the U.S., bringing patients a 1-week replacement lens so they can start and end every week fresh.(1,2) We celebrate this launch with gratitude to all Eye Care Professionals who help patients see brilliantly. Together, we're shaping the future of eye care and making a remarkable difference in patients' lives. Learn more about the newest innovation below. #AlconVoice #SeeBrilliantly #PRECISION7 #AlconUS 1.In a 2-week prospective clinical study in the US; n=181; CLEAR CARE Cleaning & Disinfecting Solution used for cleaning and disinfection; Alcon data on file, 2023. 2.Zheng Y, Dou J, Wang Y, et al. Sustained release of a polymeric wetting agent from a silicone-hydrogel contact lens material. ACS Omega. 2022;7(33):29223-29230. doi: 10.1021/acsomega.2c03310.

Outstanding comfort and precise vision even at 16 hours of wear!1 I'm proud to be a part of the PRECISION7® launch today in the U.S., bringing patients a 1-week replacement lens so they can start and end every week fresh. 1,2 We celebrate this launch with gratitude to all Eye Care Professionals who help patients see brilliantly. Together, we're shaping the future of eye care and making a remarkable difference in patients' lives. Learn more about the newest innovation below. #AlconVoice #SeeBrilliantly #PRECISION7 #AlconUS 1.In a 2-week prospective clinical study in the US; n=181; CLEAR CARE Cleaning & Disinfecting Solution used for cleaning and disinfection; Alcon data on file, 2023. 2.Zheng Y, Dou J, Wang Y, et al. Sustained release of a polymeric wetting agent from a silicone-hydrogel contact lens material. ACS Omega. 2022;7(33):29223-29230. doi: 10.1021/acsomega.2c03310.

📈 QUARTERLY REPORT   #Orthocell has today published its Quarterly Report & 4C for the period ended 31 March 2024.   Highlights for this Quarter:   ✅  Increasing revenue driven by growth in new product sales. Year to date revenue of $4.88 million is up 40.7% from $3.47 million for the same period last year. ✅  Successful completion of a $3.5 million strategic placement ✅ Strong balance sheet with $20.1m cash at bank at the end of the quarter ✅ Strengthening the Board with appointment of the Hon Kim Beazley AC ✅ Successful completion of all nerve repair surgeries in Remplir™ US market authorisation study ✅ Submission of Singapore Regulatory Application for Remplir™ in February 2024   Orthocell Managing Director, Paul Anderson, said:   “Orthocell has completed a very solid quarter, growing revenues whilst strengthening the balance sheet and share register. I am very pleased with the performance of our distribution partners and the continued increase in product adoption. With a highly respected and experienced Board now in place, we are in a strong position to continue to gain commercial traction and drive Remplir, our breakthrough nerve repair device, into global markets.”   Read today’s ASX release 👉 https://lnkd.in/gmESes_E $OCC #ASX #regenerativemedicine #biotech #innovation #health #healthcare.

Our patented nanoemulsion drug delivery system is expertly crafted to improve ocular comfort and treatment effectiveness. By optimizing drug penetration and bio-adhesion, we offer a superior solution for eye care. 🔹 Fast Spreadability: Ensures quick and even distribution over the ocular surface, maximizing therapeutic impact. 🔹 Completely Dissolved: Eliminates the need for a dissolution step, streamlining application and improving user experience. 🔹 Mucoadhesion: Prolongs exposure to the eye, maximizing absorption for better results. 🔹 Deep Penetration: Achieves effective delivery to the aqueous humor, ensuring comprehensive treatment. Explore how SVT-15473 Clobetasol ophthalmic 0.05% can make a difference in managing eye inflammation and improving patient care 👉https://lnkd.in/dXhJ2Vk4